These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1878583

  • 21. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

  • 22. Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.
    Bleyer WA, Sather HN, Nickerson HJ, Coccia PF, Finklestein JZ, Miller DR, Littman PS, Lukens JN, Siegel SE, Hammond GD.
    J Clin Oncol; 1991 Jun; 9(6):1012-21. PubMed ID: 2033414
    [Abstract] [Full Text] [Related]

  • 23. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
    Matloub Y, Lindemulder S, Gaynon PS, Sather H, La M, Broxson E, Yanofsky R, Hutchinson R, Heerema NA, Nachman J, Blake M, Wells LM, Sorrell AD, Masterson M, Kelleher JF, Stork LC, Children's Oncology Group.
    Blood; 2006 Aug 15; 108(4):1165-73. PubMed ID: 16609069
    [Abstract] [Full Text] [Related]

  • 24. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
    Ribeiro RC, Rivera GK, Hudson M, Mulhern RK, Hancock ML, Kun L, Mahmoud H, Sandlund JT, Crist WM, Pui CH.
    J Clin Oncol; 1995 Feb 15; 13(2):333-8. PubMed ID: 7844594
    [Abstract] [Full Text] [Related]

  • 25. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.
    Winick NJ, Smith SD, Shuster J, Lauer S, Wharam MD, Land V, Buchanan G, Rivera G.
    J Clin Oncol; 1993 Feb 15; 11(2):271-8. PubMed ID: 8426204
    [Abstract] [Full Text] [Related]

  • 26. [The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
    Chybicka A, Bogusławska-Jaworska J, Gorczyńska E, Juszczak K, Armata J, Balcerska A, Balwierz W, Bubała H, Filiks-Litwin B, Kołecki P, Kowalczyk J, Lukowska K, Matysiak M, Rokicka-Milewska R, Rola-Kurc E, Stencel D, Sońta-Jakimczyk D, Strojny W, Wachowiak J, Wieczorek M, Wysocki M, Zelenay E.
    Wiad Lek; 1998 Feb 15; 51 Suppl 4():25-32. PubMed ID: 10731940
    [Abstract] [Full Text] [Related]

  • 27. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun 15; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 28. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
    Schrappe M, Reiter A, Sauter S, Ludwig WD, Wörmann B, Harbott J, Bender-Götze C, Dörffel W, Dopfer R, Frey E.
    Klin Padiatr; 1994 Jun 15; 206(4):208-21. PubMed ID: 7526027
    [Abstract] [Full Text] [Related]

  • 29. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
    Veerman AJ, Hählen K, Kamps WA, Van Leeuwen EF, De Vaan GA, Solbu G, Suciu S, Van Wering ER, Van der Does-Van der Berg A.
    J Clin Oncol; 1996 Mar 15; 14(3):911-8. PubMed ID: 8622039
    [Abstract] [Full Text] [Related]

  • 30. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
    Henze G, v Stackelberg A, Eckert C.
    Klin Padiatr; 2013 May 15; 225 Suppl 1():S73-8. PubMed ID: 23700062
    [Abstract] [Full Text] [Related]

  • 31. Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report.
    Stark B, Sharon R, Rechavi G, Attias D, Ballin A, Cividalli G, Burstein Y, Sthoeger D, Abramov A, Zaizov R.
    Cancer; 2000 Jan 01; 88(1):205-16. PubMed ID: 10618625
    [Abstract] [Full Text] [Related]

  • 32. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?
    Borgmann A, Baumgarten E, Schmid H, Dopfer R, Ebell W, Göbel U, Niethammer D, Gadner H, Henze G.
    Bone Marrow Transplant; 1997 Dec 01; 20(11):939-44. PubMed ID: 9422472
    [Abstract] [Full Text] [Related]

  • 33. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.
    Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD.
    J Clin Oncol; 1993 Mar 01; 11(3):520-6. PubMed ID: 8445427
    [Abstract] [Full Text] [Related]

  • 34. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
    Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Uckun FM, Bleyer WA.
    Cancer; 1998 Feb 01; 82(3):600-12. PubMed ID: 9452280
    [Abstract] [Full Text] [Related]

  • 35. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
    Ritchey AK, Pollock BH, Lauer SJ, Andejeski Y, Barredo J, Buchanan GR.
    J Clin Oncol; 1999 Dec 01; 17(12):3745-52. PubMed ID: 10577846
    [Abstract] [Full Text] [Related]

  • 36. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P, Kun LE, Hustu HO, Mulhern RK, Hancock ML, Coffey D, Rivera GK.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):477-83. PubMed ID: 7852109
    [Abstract] [Full Text] [Related]

  • 37. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH, Camitta BM, Leventhal BG, Shuster JJ, Civin CJ, Ganick DJ, Lauer SJ, Steuber CP, Kamen BA.
    Cancer; 1995 May 15; 75(10):2623-31. PubMed ID: 7736409
    [Abstract] [Full Text] [Related]

  • 38. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul 15; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 39. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Wofford MM, Smith SD, Shuster JJ, Johnson W, Buchanan GR, Wharam MD, Ritchey AK, Rosen D, Haggard ME, Golembe BL.
    J Clin Oncol; 1992 Apr 15; 10(4):624-30. PubMed ID: 1548525
    [Abstract] [Full Text] [Related]

  • 40. Improved outcome in adult B-cell acute lymphoblastic leukemia.
    Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Löffler H, Fonatsch C, Rieder H, Heil G, Heinze B, Arnold R, Hossfeld D, Büchner T, Koch P, Freund M, Hiddemann W, Maschmeyer G, Heyll A, Aul C, Faak T, Kuse R, Ittel TH, Gramatzki M, Diedrich H, Kolbe K, Fuhr HG, Fischer K, Schadeck-Gressel C, Weiss A, Strohscheer I, Metzner B, Fabry U, Gökbuget N, Völkers B, Messerer D, Uberla K.
    Blood; 1996 Jan 15; 87(2):495-508. PubMed ID: 8555471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.